209 related articles for article (PubMed ID: 33025105)
1. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide.
Liu CH; Chang JH; Chang YC; Mou KY
J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105
[TBL] [Abstract][Full Text] [Related]
2. Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice.
Zhou H; Zhang HJ; Guan L; Zhang YN; Li Y; Sun MJ
Mol Med Rep; 2018 Dec; 18(6):5652-5662. PubMed ID: 30387820
[TBL] [Abstract][Full Text] [Related]
3. Both
Xu X; Wu J; Jin Y; Huang K; Zhang Y; Liang Z
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986214
[TBL] [Abstract][Full Text] [Related]
4. Heat-Killed
Jin Y; Wu J; Huang K; Liang Z
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474831
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
Wang C; Li W; Wang H; Ma Y; Zhao X; Zhang X; Yang H; Qian J; Li J
BMC Microbiol; 2019 Nov; 19(1):246. PubMed ID: 31694526
[TBL] [Abstract][Full Text] [Related]
6. A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii.
Garrido-Mesa J; Algieri F; Rodriguez-Nogales A; Utrilla MP; Rodriguez-Cabezas ME; Zarzuelo A; Ocete MA; Garrido-Mesa N; Galvez J
Pharmacol Res; 2015 Jul; 97():48-63. PubMed ID: 25917208
[TBL] [Abstract][Full Text] [Related]
7. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
[TBL] [Abstract][Full Text] [Related]
8.
Gao H; Li Y; Sun J; Xu H; Wang M; Zuo X; Fu Q; Guo Y; Chen Z; Zhang P; Li X; Wang N; Ye T; Yao Y
Oxid Med Cell Longev; 2021; 2021():1622375. PubMed ID: 34367460
[No Abstract] [Full Text] [Related]
9. A comparative evaluation of the kefir yeast
Youn HY; Kim HJ; Kim H; Seo KH
Food Funct; 2024 Jun; 15(12):6717-6730. PubMed ID: 38833212
[TBL] [Abstract][Full Text] [Related]
10. The Probiotic Effects of the
Lee JE; Lee E
J Microbiol Biotechnol; 2022 Jul; 32(7):877-884. PubMed ID: 35791078
[TBL] [Abstract][Full Text] [Related]
11.
Li B; Zhang H; Shi L; Li R; Luo Y; Deng Y; Li S; Li R; Liu Z
Food Funct; 2022 Jan; 13(1):102-112. PubMed ID: 34878454
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Saccharomyces boulardii in a rat model of colitis.
Soyturk M; Saygili SM; Baskin H; Sagol O; Yilmaz O; Saygili F; Akpinar H
World J Gastroenterol; 2012 Nov; 18(44):6452-60; discussion p. 6459. PubMed ID: 23197891
[TBL] [Abstract][Full Text] [Related]
13. Low concentrations of human neutrophil peptide ameliorate experimental murine colitis.
Maeda T; Sakiyama T; Kanmura S; Hashimoto S; Ibusuki K; Tanoue S; Komaki Y; Arima S; Nasu Y; Sasaki F; Taguchi H; Numata M; Uto H; Tsubouchi H; Ido A
Int J Mol Med; 2016 Dec; 38(6):1777-1785. PubMed ID: 27840892
[TBL] [Abstract][Full Text] [Related]
14. Modulation in Natriuretic Peptides System in Experimental Colitis in Rats.
Lee CH; Ha GW; Kim JH; Kim SH
Dig Dis Sci; 2016 Apr; 61(4):1060-8. PubMed ID: 26660905
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I
PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice.
Dong JP; Zheng Y; Wu T; He Q; Teng GG; Wang HH
Chin Med J (Engl); 2019 Aug; 132(16):1951-1958. PubMed ID: 31335471
[TBL] [Abstract][Full Text] [Related]
17. Intervention with fructooligosaccharides,
Wu Y; Fu H; Xu X; Jin H; Kao QJ; Teng WL; Wang B; Zhao G; Pi XE
Front Microbiol; 2024; 15():1356365. PubMed ID: 38835484
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Effect of Herbal Formulation KM1608 on Inflammatory Bowl Diseases: A Preliminary Experimental Study.
Shin MS; Kim SB; Lee J; Choi HS; Park J; Park JY; Lee S; Hwang GS; Koo BA; Kang KS
Molecules; 2018 Aug; 23(8):. PubMed ID: 30126158
[No Abstract] [Full Text] [Related]
19. Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis.
Jawhara S; Poulain D
Med Mycol; 2007 Dec; 45(8):691-700. PubMed ID: 17885943
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of gentiopicroside against dextran sodium sulfate induced colitis in mice.
Niu YT; Zhao YP; Jiao YF; Zheng J; Yang WL; Zhou R; Niu Y; Sun T; Li YX; Yu JQ
Int Immunopharmacol; 2016 Oct; 39():16-22. PubMed ID: 27394986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
